Epstein File EFTA01114097: Charles, Citibank and Treat (DS9)

Epstein Index›Documents›EFTA01114097

⚡IMPACT LEVEL 3 — NOTEWORTHY

Epstein File EFTA01114097: Charles, Citibank and Treat (DS9)

General DocumentDate unavailableEFTA011140971 keyword hits

0

views

0

shares

0

reactions

1

persons

2

keywords

4

excerpts

This document appears to be a business model or financial analysis document referencing multiple financial institutions including Citibank, Charles Schwab, and UBS, with percentage allocations and account information. The document also discusses the DigniCap system, a medical device used to reduce hair loss during chemotherapy, and mentions distributors and business models in various countries.

👤 Named in This Document

Charles

🔑 Evidence Keywords

Citibank treat

📋 Key Excerpts4

PersonKeyword

Excerpt 1

Pierce, Fenner & Smith Inc. 371 064 2,2% BUSINESS MODEL Semmy Rulf 335 079 2,0% The DigniCap system is sold to distributors as a stand-alone system in **Citibank**

Excerpt 2

, CBNY-Charles Schwab, New York 254 233 1,5% **Citibank**, CBLDN-UBS, London 152 000 0,9% most countries in Europe and in Asia.

Excerpt 3

DigniCap reduces hair loss when ganization and new business model in USA, "paid per **treat**- patients are going through chemotherapy and has been used world